Print Page as PDF
VBECS set field level write access for file 63 ICR (4469)

VBECS set field level write access for file 63    ICR (4469)

Name Value
NUMBER 4469
IA # 4469
GLOBAL ROOT DD(63,
DATE CREATED 2004/07/23
CUSTODIAL PACKAGE VA FILEMAN
CUSTODIAL ISC San Francisco
USAGE Private
TYPE File
NAME VBECS set field level write access for file 63
GENERAL DESCRIPTION
The VistA Blood Establishment Computer Software (VBECS)
data conversion application would like to change the write access for specific
fields in the LAB DATA file (63).

The following sub-files and fields will be targeted:
----------------------------------------------------
BLOOD BANK (Multiple-63.01), [BB;0]
.01  DATE/TIME SPECIMEN TAKEN (RDX), [0;1]
.03  DATE REPORT COMPLETED (RD), [0;3]
.04  ENTERING PERSON (P200'), [0;4]
.05  SPECIMEN (P61'), [0;5]
.055 COLLECTION SAMPLE (RP62'), [0;11]
.06  ACCESSION NUMBER (F), [0;6]
.07  PHYSICIAN (*P200'X), [0;7]
.08  WARD (F), [0;8]
.09  PHLEBOTOMIST (P200'), [0;9]
.1   DATE/TIME RECEIVED (RDX), [0;10]
.12  ACCESSION LINK (FI), [0;12]
.99  SPECIMEN COMMENT (Multiple-63.199), [99;0]
.01  SPECIMEN COMMENT (MF), [0;1]
2.1  DIRECT AHG(POLYSPECIFIC) (FX), [2;1]
2.2  DIRECT AHG(5 min incub) (FX), [2;2]
2.3  DIRECT AHG CC (FX), [2;3]
2.4  ANTI-IgG (FX), [2;4]
2.5  ANTI-IgG CC (FX), [2;5]
2.6  ANTI-COMPLEMENT (FX), [2;6]
2.7  ANTI-COMPLEMENT (5 min incub) (FX), [2;7]
2.8  ANTI-COMPLEMENT CC (FX), [2;8]
2.9  DIRECT AHG INTERPRETATION (S), [2;9]
2.91 DIRECT AHG TEST COMMENT (FX), [2;10]
3    ELUATE ANTIBODY (Multiple-63.012), [EA;0]
.01  ELUATE ANTIBODY (M*P61.3'X), [0;1]
4    SCREEN CELL METHOD (Multiple-63.014), [3;0]
.01  SCREEN CELL METHOD (MS), [0;1]
.02  TECHNIQUE (S), [0;2]
1    SCREEN CELL (Multiple-63.015), [1;0]
.01  SCREEN CELL (MSX), [0;1]
.02  SOURCE (P66'), [0;2]
.03  INTERPRETATION (S), [0;3]
.04  IS (FX), [0;4]
.05  37 C (FX), [0;5]
.06  AHG (FX), [0;6]
.07  CONTROL CELL (FX), [0;7]
.08  ROOM TEMP (FX), [0;8]
.09  12-18 C (FX), [0;9]
.1   4 C (FX), [0;10]
6    ANTIBODY SCREEN INTERPRETATION (S), [6;1]
6.1  RBC ANTIGEN PRESENT (Multiple-63.011), [1.1;0]
.01  RBC ANTIGEN PRESENT (M*P61.3'X), [0;1]
.02  COMMENT (F), [0;2]
6.2  RBC ANTIGEN ABSENT (Multiple-63.0112), [1.2;0]
.01  RBC ANTIGEN ABSENT (M*P61.3'X), [0;1]
.02  COMMENT (F), [0;2]
6.3  HLA ANTIGEN PRESENT (Multiple-63.013), [1.3;0]
.01  HLA ANTIGEN PRESENT (M*P61.3'X), [0;1]
.02  COMMENT (F), [0;2]
6.4  HLA ANTIGEN ABSENT (Multiple-63.0114), [1.4;0]
.01  HLA ANTIGEN ABSENT (M*P61.3'X), [0;1]
.02  COMMENT (F), [0;2]
7    SERUM ANTIBODY (Multiple-63.46), [5;0]
.01  SERUM ANTIBODY (M*P61.3'X), [0;1]
.02  ANTIBODY COMMENT (F), [0;2]
8    ANTIBODY SCREEN COMMENT (Multiple-63.48), [4;0]
.01  ANTIBODY SCREEN COMMENT (MFX), [0;1]
9    RBC TYPING METHOD (Multiple-63.018), [1;0]
.01  RBC TYPING METHOD (S), [0;1]
.02  TECHNIQUE (S), [0;2]
1    ANTISERUM (Multiple-63.019), [1;0]
.01  ANTISERUM (M*P66'), [0;1]
.02  LOT # (F), [0;2]
.03  INTERPRETATION (RS), [0;3]
.04  IS (FX), [0;4]
.05  37 C (FX), [0;5]
.06  AHG (FX), [0;6]
.07  CONTROL CELL (FX), [0;7]
.08  ROOM TEMP (FX), [0;8]
.09  12-18 C (FX), [0;9]
.1   4 C (FX), [0;10]
121  PT CELLS+ANTI D (sal) (FX), [12;1]
122  PT CELLS+RH CTRL (sal) (FX), [12;2]
123  PT CELLS(sal)+ANTI D(hp IS) (FX), [12;3]
124  PT CELLS(ser)+ANTI D(hp IS) (RFX), [12;4]
125  PT CELLS+ANTI D (hp 37) (FX), [12;5]
126  PT CELLS+ANTI D (hp AHG) (FX), [12;6]
127  PT CELLS+ANTI D SLIDE (hp) (S), [12;7]
128  PT CELLS(sal)+RH CTRL (hp IS) (FX), [12;8]
129  PT CELLS(ser)+RH CTRL(hp IS) (RFX), [12;9]
129.1PT CELLS+RH CTRL (hp 37) (FX), [12;10]
129.11PT CELLS+RH CTRL (hp AHG) (FX), [12;11]
129.12PT CELLS+RH CTRL SLIDE (hp) (S), [12;12]
131  INTERPRETATION OF RH TESTING (RS), [13;1]
132  RH TEST COMMENT (F), [13;2]
GLOBAL REFERENCE
GLOBAL REFERENCE FIELD NUMBER
DD(63.01,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman DATE/TIME SPECIMEN TAKEN 0;1
.03 Direct Global Write & w/Fileman DATE REPORT COMPLETED 0;3
.04 Direct Global Write & w/Fileman ENTERING PERSON 0;4
.05 Direct Global Write & w/Fileman SPECIMEN 0;5
.055 Direct Global Write & w/Fileman COLLECTION SAMPLE 0;11
.06 Direct Global Write & w/Fileman ACCESSION NUMBER 0;6
.07 Direct Global Write & w/Fileman PHYSICIAN 0;7
.08 Direct Global Write & w/Fileman WARD 0;8
.09 Direct Global Write & w/Fileman PHLEBOTOMIST 0;9
.1 Direct Global Write & w/Fileman DATE/TIME RECEIVED 0;10
.12 Direct Global Write & w/Fileman ACCESSION LINK 0;12
.99 Direct Global Write & w/Fileman SPECIMEN COMMENT mult-63.199
2.1 Direct Global Write & w/Fileman DIRECT AHG(POLYSPECIFIC) 2;1
2.2 Direct Global Write & w/Fileman DIRECT AHG(5 min incub) 2;2
2.3 Direct Global Write & w/Fileman DIRECT AHG CC 2;3
2.4 Direct Global Write & w/Fileman ANTI-IgG 2;4
2.5 Direct Global Write & w/Fileman ANTI-IgG CC 2;5
2.6 Direct Global Write & w/Fileman ANTI-COMPLEMENT 2;6
2.7 Direct Global Write & w/Fileman ANTI-COMPLEMENT (5 min incub) 2;7
2.8 Direct Global Write & w/Fileman ANTI-COMPLEMENT CC 2;8
2.9 Direct Global Write & w/Fileman DIRECT AHG INTERPRETATION 2;9
2.91 Direct Global Write & w/Fileman DIRECT AHG TEST COMMENT 2;10
3 Direct Global Write & w/Fileman ELUATE ANTIBODY mult-63.012
4 Direct Global Write & w/Fileman SCREEN CELL METHOD mult-63.014
6 Direct Global Write & w/Fileman ANTIBODY SCREEN INTERPRETATION 6;1
6.1 Direct Global Write & w/Fileman RBC ANTIGEN PRESENT mult-63.011
6.2 Direct Global Write & w/Fileman RBC ANTIGEN ABSENT mult-63.0112
6.3 Direct Global Write & w/Fileman HLA ANTIGEN PRESENT mult-63.013
6.4 Direct Global Write & w/Fileman HLA ANTIGEN ABSENT mult-63.0114
7 Direct Global Write & w/Fileman SERUM ANTIBODY mult-63.46
8 Direct Global Write & w/Fileman ANTIBODY SCREEN COMMENT mult-63.48
9 Direct Global Write & w/Fileman RBC TYPING METHOD mult-63.018
121 Direct Global Write & w/Fileman PT CELLS+ANTI D 12;1
122 Direct Global Write & w/Fileman PT CELLS+RH CTRL 12;2
123 Direct Global Write & w/Fileman PT CELLS(sal)+ANTI D(hp IS) 12;3
124 Direct Global Write & w/Fileman PT CELLS(ser)+ANTI D(hp IS) 12;4
125 Direct Global Write & w/Fileman PT CELLS+ANTI D (hp 37) 12;5
126 Direct Global Write & w/Fileman PT CELLS+ANTI D (hp AHG) 12;6
127 Direct Global Write & w/Fileman PT CELLS+ANTI D SLIDE (hp) 12;7
128 Direct Global Write & w/Fileman PT CELLS(sal)+RH CTRL (hp IS) 12;8
129 Direct Global Write & w/Fileman PT CELLS(ser)+RH CTRL(hp IS) 12;9
129.1 Direct Global Write & w/Fileman PT CELLS+RH CTRL (hp 37) 12;10
129.11 Direct Global Write & w/Fileman PT CELLS+RH CTRL (hp AHG) 12;11
129.12 Direct Global Write & w/Fileman PT CELLS+RH CTRL SLIDE (hp) 12;12
131 Direct Global Write & w/Fileman INTERPRETATION OF RH TESTING 13;1
132 Direct Global Write & w/Fileman RH TEST COMMENT 13;2
133 Direct Global Write & w/Fileman PT Cells(sal)+Anti D(mod) IS 13;3
134 Direct Global Write & w/Fileman PT Cells(ser)+Anti D(mod) IS 13;4
135 Direct Global Write & w/Fileman PT Cells+Anti D(mod) 37 13;5
136 Direct Global Write & w/Fileman PT Cells+Anti D(mod) AHG 13;6
138 Direct Global Write & w/Fileman PT Cells(sal)+RH Ctrl(sal) IS 13;8
139 Direct Global Write & w/Fileman PT Cells(ser)+RH Ctrl(sal) IS 13;9
139.1 Direct Global Write & w/Fileman PT Cells+RH Ctrl(sal) 37 13;10
139.11 Direct Global Write & w/Fileman PT Cells+RH Ctrl(sal) AHG 13;11
141 Direct Global Write & w/Fileman PT CELLS(ser)+ANTI A IS 14;1
142 Direct Global Write & w/Fileman PT CELLS(sal)+ANTI A IS 14;2
143 Direct Global Write & w/Fileman PT CELLS+ANTI A SLIDE 14;3
144 Direct Global Write & w/Fileman PT CELLS(ser)+ANTI B IS 14;4
145 Direct Global Write & w/Fileman PT CELLS(sal)+ANTI B IS 14;5
146 Direct Global Write & w/Fileman PT CELLS+ANTI B SLIDE 14;6
147 Direct Global Write & w/Fileman PT CELLS(ser)+ANTI A,B IS 14;7
148 Direct Global Write & w/Fileman PT CELLS(ser)+ANTI A,B (RT) 14;8
149 Direct Global Write & w/Fileman PT CELLS(sal)+ANTI A,B (IS) 14;9
149.1 Direct Global Write & w/Fileman PT CELLS(sal)+ANTI A,B (RT) 14;10
149.11 Direct Global Write & w/Fileman PT CELLS+ANTI A,B SLIDE 14;11
149.12 Direct Global Write & w/Fileman PT SERUM+A1 CELLS 14;12
149.13 Direct Global Write & w/Fileman PT SERUM+B CELLS 14;13
151 Direct Global Write & w/Fileman INTERPRETATION OF ABO TESTING 15;1
152 Direct Global Write & w/Fileman ABO TESTING COMMENT 15;2
153 Direct Global Write & w/Fileman INTERPRETATION ABO GROUP(cell) 15;3
154 Direct Global Write & w/Fileman INTERPRETATION ABO GROUP(ser) 15;4
DD(63.199,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman SPECIMEN COMMENT 0;1
DD(63.012,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman ELUATE ANTIBODY 0;1
DD(63.014,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman SCREEN CELL METHOD 0;1
.02 Direct Global Write & w/Fileman TECHNIQUE 0;2
1 Direct Global Write & w/Fileman SCREEN CELL mult-63.015
DD(63.015,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman SCREEN CELL 0;1
.02 Direct Global Write & w/Fileman SOURCE 0;2
.03 Direct Global Write & w/Fileman INTERPRETATION 0;3
.04 Direct Global Write & w/Fileman IS 0;4
.05 Direct Global Write & w/Fileman 37 C 0;5
.06 Direct Global Write & w/Fileman AHG 0;6
.07 Direct Global Write & w/Fileman CONTROL CELL 0;7
.08 Direct Global Write & w/Fileman ROOM TEMP 0;8
.09 Direct Global Write & w/Fileman 12-18 C 0;9
.1 Direct Global Write & w/Fileman 4 C 0;10
DD(63.011,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman RBC ANTIGEN PRESENT 0;1
.02 Direct Global Write & w/Fileman COMMENT 0;2
DD(63.0112,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman RBC ANTIGEN ABSENT 0;1
.02 Direct Global Write & w/Fileman COMMENT 0;2
DD(63.013,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman HLA ANTIGEN PRESENT 0;1
2 Direct Global Write & w/Fileman COMMENT 0;2
DD(63.0114,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman HLA ANTIGEN ABSENT 0;1
2 Direct Global Write & w/Fileman COMMENT 0;2
DD(63.46,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman SERUM ANTIBODY 0;1
.02 Direct Global Write & w/Fileman ANTIBODY COMMENT 0;2
DD(63.48,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman ANTIBODY SCREEN COMMENT 0;1
DD(63.018,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman RBC TYPING METHOD 0;1
.02 Direct Global Write & w/Fileman TECHNIQUE 0;2
1 Direct Global Write & w/Fileman ANTISERUM mult-63.019
DD(63.019,
FIELD NUMBER ACCESS FIELD NAME LOCATION
.01 Direct Global Write & w/Fileman ANTISERUM 0;1
.02 Direct Global Write & w/Fileman LOT # 0;2
.03 Direct Global Write & w/Fileman INTERPRETATION 0;3
.04 Direct Global Write & w/Fileman IS 0;4
.05 Direct Global Write & w/Fileman 37 C 0;5
.06 Direct Global Write & w/Fileman AHG 0;6
.07 Direct Global Write & w/Fileman CONTROL CELL 0;7
.08 Direct Global Write & w/Fileman ROOM TEMP 0;8
.09 Direct Global Write & w/Fileman 12-18 C 0;9
.1 Direct Global Write & w/Fileman 4 C 0;10
STATUS Withdrawn
KEYWORDS
  • Blood Bank
  • write access
  • data dictionary
  • Lab Data
DURATION Till Otherwise Agreed
EXPIRATION DATE OCT 2005
ID DD(63,